Li Ning

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.

Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.

Journal: EClinicalMedicine
Published: September 23, 2024

Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention.

Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention.

Journal: Frontiers in medicine
Published: November 07, 2022

Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer.

Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer.

Journal: BMC cancer
Published: April 11, 2022

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.

Journal: BMC cancer
Published: September 09, 2021

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer.

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer.

Journal: OncoTargets and therapy
Published: April 07, 2019

Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).

Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).

Journal: Medicine
Published: August 11, 2018

Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.

Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.

Journal: International journal of oncology
Published: May 29, 2018

CAR-T cell therapy in ovarian cancer: from the bench to the bedside.

CAR-T cell therapy in ovarian cancer: from the bench to the bedside.

Journal: Oncotarget
Published: April 26, 2017

Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis.

Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis.

Journal: Oncotarget
Published: March 22, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026